Track OptimizeRx Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

OptimizeRx Corporation OPRX Open OptimizeRx Corporation in new tab

4.83 USD
P/E
14.47
EPS
0.36
P/B
0.76
ROE
5.56
Beta
1.19
Target Price
11.50 USD
OptimizeRx Corporation logo

OptimizeRx Corporation

🧾 Earnings Recap – Q3 2025

OptimizeRx reported a robust Q3 2025 with revenues of $26.1 million, reflecting a 22% year-over-year growth, and an adjusted EBITDA of $5.1 million, exceeding expectations.

  • Revenue guidance for FY 2025 has been raised to $105-$109 million, with adjusted EBITDA now expected between $16-$19 million.
  • Average revenue from the top 5 customers has grown beyond $11 million, demonstrating strong client relationships and engagement.
  • The company continues to reduce its debt, paying down an additional $2 million, and does not anticipate needing to access equity capital markets in the near future.
  • Gross margin improved to 67.2%, driven by a favorable product and channel mix, alongside disciplined cost management efforts.
  • Initial guidance for FY 2026 indicates revenue of $118-$124 million and adjusted EBITDA of $19-$22 million, signaling confidence in future growth.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E14.47
EPS0.36
Book Value6.84
Price to Book0.76
Debt/Equity18.30
% Insiders11.845%
Growth
Revenue Growth-0.10%
Estimates
Forward P/E4.93
Forward EPS1.06
Target Mean Price11.50

DCF Valuation

Tweak assumptions to recompute fair value for OptimizeRx Corporation (OPRX)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

OptimizeRx Corporation Logo OptimizeRx Corporation Analysis (OPRX)

United States Health Care Official Website Stock

Is OptimizeRx Corporation a good investment? OptimizeRx Corporation (OPRX) is currently trading at 4.83 USD. Market analysts have a consensus price target of 11.50 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 14.47. This relatively low multiple may signal that OptimizeRx Corporation is undervalued compared to historical market norms.

Earnings Schedule: OptimizeRx Corporation is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 1.06.

Investor FAQ

Does OptimizeRx Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is OptimizeRx Corporation?

OptimizeRx Corporation is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.36.

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
NCM (Australia) OPRX

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion